BIIB CIK: 875045

Biogen Inc.

  • United States
  • Healthcare
  • Pharma
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
billions USD
FY21:
3.64
FY22:
1.38
FY23:
1.55
FY24:
2.88
FY25:
2.20
Change from FY21 to FY25
billions USD
FY21:
−0.56
FY22:
1.58
FY23:
−4.10
FY24:
−0.80
FY25:
−1.37
Change from FY21 to FY25
billions USD
FY21:
−2.09
FY22:
−1.75
FY23:
0.15
FY24:
−0.68
FY25:
−0.30
(positive)
Change from FY21 to FY25
billions USD
FY21:
3.38
FY22:
1.14
FY23:
1.27
FY24:
2.72
FY25:
2.05

All amounts in billions USD Data source:SEC EDGAR